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Pluripotent stem cells can undergo repeated self-renewal while retaining genetic integrity, but they occasionally acquire aneuploidy dur-
ing long-term culture, which is a practical obstacle for medical applications of human pluripotent stem cells. In this study, we explored
the biological roles of ABR, a regulator of RHO family small GTPases, and found that it has pivotal roles duringmitotic processes in human
embryonic stem cells (hESCs). Although ABR has been shown to be involved in dissociation-induced hESC apoptosis, it does not appear
to have direct effects on cell survival unless cell-cell contact is impaired. Instead, we found that it is important for faithful hESC division.
Mechanistically, ABR depletion compromised centrosome dynamics and predisposed the cell to chromosome misalignment and misse-
gregation, which raised the frequency of aneuploidy. These results provide insights into the mechanisms that support the genetic integ-
rity of self-renewing hESCs.
INTRODUCTION
The faithful inheritance of genetic material during repeti-
tive cell division is fundamental for animal development
and tissue regeneration in multicellular organisms. Several
quality control mechanisms survey the organism for ge-
netic normality and then activate programs for error
correction or elimination of abnormal cells. These mech-
anisms could suppress aneuploidy, a genetic aberration
that arises from missegregation of whole chromosomes
during mitosis. If aneuploid cells override these barriers
and continue proliferating, they can acquire cancerous
properties. It is well recognized that chromosomal insta-
bility, the condition in which aneuploidy occurs at
a high rate, underlies genetic abnormalities found in
many types of tumor cells. Actually, aneuploidy is
commonly observed in a wide range of tumor tissues
and cancer-derived cell lines (reviewed in Santaguida
and Amon, 2015).
Pluripotent stem cells, such as embryonic stem cells
(ESCs) and induced pluripotent stem cells (iPSCs), have
special abilities to differentiate into cells of all three germ
layers (pluripotency) and to undergo unlimited prolifera-
tion while retaining their identities (self-renewal) (Nichols
and Smith, 2012). In addition, they are known to be able to
maintain genetic integrity, which is an essential require-
ment for their utilization in genetic studies or medical
applications. Maintaining chromosome number is particu-
larly important in pluripotent stem cells because aneu-
ploidy can lead not only to oncogenic transformation but
also to differentiation dysregulation (Peterson and Loring,
2014; Ben-David et al., 2014; Lamm et al., 2016; Zhang
et al., 2016). Nevertheless, aneuploidy is often observed
in some human ESC (hESC) and iPSC lines (Spits
et al., 2008; Mayshar et al., 2010; Taapken et al., 2011).
A screening study of a large number of hESC/iPSC lines
documented a progressive tendency to acquire karyotypic
abnormality during long-term culture, indicating a cul-
ture-associated susceptibility to aneuploidy (International
Stem Cell Initiative et al., 2011). Although previous reports
describe several putative risks contributing to chromosome
instability, including excessive replication stresses and
DNA damage responses (Zhao et al., 2015; Lamm et al.,
2016; Jacobs et al., 2016), safeguarding mechanisms to
counteract these threats remain to be elucidated.
We previously reported that the aberrant activation of
the RHO-ROCK pathway was responsible for dissociation-
induced hESC apoptosis (Watanabe et al., 2007; Ohgushi
et al., 2010). We also identified ABR, a modulator of RHO
family small GTPase activities, as an upstream factor
controlling the survival-or-death decision of dissociated
hESCs. The ROCK activation is thought to affect cellular
motility (Li et al., 2010), but whether this phenomenon
represents any biological implications has remained a
mystery. To tackle this question, we sought to explore
ABR function. We found that ABR did not have direct
effects on cell survival unless cell-cell contact was impaired.
Instead, we obtained unexpected data indicating that ABR
depletion increased the frequency of chromosome misse-
gregation. These findings shed light on the safeguarding
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mechanism that prevents chromosomal instability in
hESCs.
RESULTS
ABR Depletion Caused Cellular Accumulation at the
G2-M Phase of the Cell Cycle
To examine ABR functions in hESCs, we applied a doxycy-
cline (dox)-inducible short hairpin RNA expression strat-
egy (Figure S1A, and refer to Ohgushi et al., 2015). This
method permitted the selective depletion of target mole-
cules with controlled timing and under the same genotypic
background. We succeeded in reducing ABR protein to
an undetectable level after dox addition (Figure 1A), and
we refer to these genetically engineered cells as tet-shABR
hESCs. To address the putative primary responses caused
by ABR depletion, we first examined cellular behaviors on
day 3 of dox treatment when the ABR protein level seemed
to reach a minimum (Figure S1B). The expression levels of
pluripotentmarkers were nearly equal between control and
dox-treated cells (Figures S1C and S1D). The number of
dead cells significantly increased after dox treatment, but
the extent was not substantial (Figure S1E). At this time
point, it was the cell cycle profile that we found remarkably
different between dox-treated and untreated tet-shABR
cells (Figures 1B and 1C).
ESCs are known to exhibit a characteristic cell cycle
pattern that includes an abbreviated G1 phase and domi-
nant occupancy of replicating S phase cells (Boward et al.,
2016). Indeed, our control cells exhibited this typical
pattern (Figure 1B, left). Interestingly, in dox-treated cells,
the S phase population was decreased while the G2 and
M populations were greatly increased (Figure 1B, right),
Figure 1. ABR Depletion Leads to G2-M
Accumulation
(A) Western blotting analyses. The tet-
shABR cells were cultured with or without
dox for 3 days. HSC70 was examined as a
loading control.
(B and C) Cell cycle profile of dox-treated
(right) or untreated (left) tet-shABR cells.
The histograms show representative results
from three independent experiments (B).
The occupancy of each phase in the
analyzed cells is indicated in these histo-
grams and also shown as a bar graph (C).
(D) Population dominance of S versus G2-M
phase is represented as the ratio of S to
G2-M phase cells.
(E) FUCCI-expressing tet-shABR cells were
cultured with or without dox for 72 hr. Cells
were classified into the indicated five cat-
egories according to the time length of one
round of cell cycle (n = 20 from three in-
dependent imaging experiments).
(F) Growth curve of tet-shABR cells that
were cultured with or without dox for 8 days.
(G) Rescue experiments. The expression
of RNAi-resistant ABR mutants (Abr*)
lacking the GEF domain (DDH) but not GAP
domain (DDH) in ABR-depleted hESC re-
stores S phase dominance. ABR* was used
as a positive control.
All experiments were repeated three times
and data are shown as representative (A
and B), bar graphs (C, D, and G), or a scat-
terplot (F). Error bars in graphs represent SD
(C, D, F, and G). Statistics: Dunnett’s test
(G, n = 3) versus lane 2; n.s., not significant
and **p < 0.05. See also Figure S1.
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Figure 2. ABR Controls Centrosome Dynamics
(A) Centrosomes are visualized by gTUBULIN staining (green). Mitosis or interphase is determined by chromosomal staining pattern and
morphology (gray).
(B–E) Live imaging analyses of control or dox-treated tet-shABR cells expressing mVenus-CENT2. (B) Snapshots from Movie S1. The
distance between centrosomes was measured with 2-min intervals. t = 0 corresponds to separation starting time, defined as a no-return
point of bilateral movement. Arrows indicate NEB onsets. (D) The durations from separation initiation to NEB. The y axis corresponds to the
(legend continued on next page)
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resulting in an inversion in population dominancy (Figures
1C and 1D). These observations demonstrate that ABR-
depleted hESCs accumulate at the G2-to-M stage. To
further confirm this, S phase cells were labeled with a tran-
sient bromodeoxyuridine supplementation, and then
traced during the subsequent 12 hr (Figures S1F–S1G). In
control cells, the labeled population passed through
G2-M into the next G1 phase. In dox-treated cells, how-
ever, labeled cells seemed to be trapped at the 4N state
and struggled to proceed into the next cycle, suggesting
that ABR-depleted cells had trouble entering or exiting
mitosis. In addition to these population analyses, we per-
formed single-cell tracing using tet-shABR cells expressing
a FUCCI reporter (Figure S1H, Sakaue-Sawano et al.,
2008). This revealed the tendency of ABR-depleted cells
to take longer times to complete one round of a cell cycle
than did control cells (Figure 1E). Consequently, ABR-
depleted cells showed significant growth retention when
cultured for a further extended period (Figure 1F).
ABR protein has a unique domain structure: a guanine
nucleotide exchanging factor (GEF) domain at the N termi-
nus and a GTPase-activating protein (GAP) domain at the
C terminus (Figure S1I). When isolated and tested by
in vitro assay, these domains were shown to possess GEF
and GAP activities for the selected members of RHO family
small GTPases (Heisterkamp et al., 1993; Chuang et al.,
1995). We sought to determine which domain is respon-
sible for ABR’s ability to drive cell cycle progression by
restoring ABR expression using RNAi-resistant or domain-
deleted mutants (Figure 1G). The introduction of codon-
swapped RNAi-immune mutant (ABR*) into tet-shABR
hESCs restored the S phase dominance. A partial restora-
tion was observed when an ABR mutant lacking a GEF
domain was introduced. On the other hand, a GAP-dead
mutant showed little rescuing effects, indicating the
importance of GAP activity for ABR.
In sum, these results show that ABR plays a key role in cell
cycle progression fromG2-M to the next G1 phase through
its GAP activity.
Compromised Centrosome Dynamics upon ABR
Depletion
To obtain mechanistic insights into the accumulation of
ABR-depleted cells in the G2-M phase, we focused on the
centrosome, a central organelle that operates multiple
mitotic events (Tanenbaum and Medema, 2010). Centro-
somes were replicated during S phase, matured at G2 phase
and separated bilaterally in parallel with M phase entry
(Figure 2A), all of which are important prerequisites for
proper cell division. In both control and dox-treated cells,
duplicated centrosomes were evident at prophase (data
not shown). The phosphorylation level of a centrosomal
kinase AURORA-A (AURKA) did not demonstrate a substan-
tial difference in centrosome maturation (Figures S2A–
S2C). Otherwise, by monitoring centrosome dynamics us-
ing tet-shABR hESCs expressing mVenus-fused centrin-2
(CETN2), a component of the centrosome, we found that
it took longer in dox-treated cells for each centrosome to
move to the opposite side (Figure 2B and Movie S1).
Notably, whereas in control cells the nuclear envelope
breakdown (NEB) occurred immediately after centrosomes
started to move bilaterally, a much longer time was needed
for NEB to take place in dox-treated cells (Figures 2B and
2C). As a consequence, inter-centrosomal distances at the
time of NEB were significantly increased in ABR-depleted
cells (Figure 2D). These observations raise the possibility
that anomalous centrosome behaviors could be a mecha-
nistic link between ABR dysfunction and G2-M accumula-
tion. In support of this idea, it has been reported that RAC,
a downstream small GTPase of ABR,modulates centrosome
movement during G2-to-M progression in cultured epithe-
lial cells (Woodcock et al., 2010; Whalley et al., 2015).
Multiple Mitotic Failures in ABR-Depleted hESCs
A number of previous studies indicate that compromised
centrosome separation often leads to severe failures in
mitotic processes (Nam et al., 2015). To observe mitosis
processes in cells with reduced ABR expression, we moni-
tored cell cycle progression using tet-shABR hESCs express-
ing fluorescence protein-fused H2B (a marker for chromo-
somes), a-tubulin (TUBA, a marker for mitotic spindle)
and Lifeact (a marker for actin filament) (Figures 3A–3C,
Movie S2, part 1 and Figure S2D for a control experiment).
Through these live imaging studies, we first found that a
substantial number of dox-treated cells faced unrecover-
able mitotic errors, including cell death or cytokinesis fail-
ures (Figures 3A, 3B and 3D; Movie S2, parts 2 and 3). Most
of these cells had encountered problems in chromosomal
alignment before these serious errors. Looking into these
data more carefully, we also found that the majority of
dox-treated cells struggled to align chromosomes at the
central plane and spent significantly extended times before
exiting frommitosis, even if they were finally able to divide
(Figures 3C and 3E; Movie S2, part 4). In addition to these
red line-gated periods indicated in (C) control (n = 50) and dox-treated cells (n = 36) were analyzed. (E) The distance between centrosomes
at the time of NEB. The y axis corresponds to blue line-gated lengths indicated in (C) control (n = 41) and dox-treated cells (n = 32) were
analyzed.
The imaging experiments were performed three times. Scale bars represent 10 mm. Error bars in the graphs represent SD (D and E). Sta-
tistics: Student’s t test (D and E); ***p < 0.001 and **p < 0.01. See also Figure S2 and Movie S1.
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Figure 3. Multiple Mitotic Failures upon ABR Depletion
(A–E) Snap shots from Movie S2. Live imagings were performed using dox-treated tet-shABR cells expressing fluorescent protein-tagged
H2B (chromosome, blue or gray), a-tubulin (TUBA, mitotic spindle, green) and LifeAct (F-actin, red). Examples of cytokinesis error (A),
(legend continued on next page)
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live imaging data, our immunostaining analyses using
metaphase-arrested cells showed a high frequency of spin-
dle malformation, which might arise from defects in
centrosome separation, aswell asmisaligned chromosomes
in dox-treated cells (Figures 3G and 3H).
Thus, ABR-depleted cells encountered serious difficulties
in chromosome alignment at metaphase, which delayed
their transition into anaphase. Thismight be another cause
for the accumulation of ABR-depleted cells in the G2-M
stage (Figure 1B).
Chromosomal Missegregation and Aneuploidy in
ABR-Depleted hESCs
Despite these troubles during prophase or metaphase,
a large fraction of ABR-depleted cells did proceed to
anaphase. This indicates that ABR is not absolutely
required for hESCs to complete cell division. The extended
period for metaphase-to-anaphase transition implies the
activation of salvage mechanisms that serve as a backup
when normal processes are disrupted (Musacchio, 2015).
In these cases, however, we repeatedly observed lagging
chromosomes during anaphase-to-telophase progression
and a resultant micronucleus formation in the daughter
cells (Figure 4A; Movie S3). Immunostaining analyses re-
vealed that ABR depletion increased the incidence of these
signs for chromosome missegregation (Figures 4B, 4C, and
S3B; S3A shows typical staining patterns). From these data,
we speculated that hESCs are able to bypass amitotic neces-
sity of ABR with the help of salvage mechanisms, but this
process renders the cell susceptible to erroneous chromo-
some segregation.
We postulated that such an error-prone situation would
yield a selective pressure to facilitate the emergence of
aneuploid cells. With this in mind, we carefully examined
chromosome counts in the mitotic spreads that were pre-
pared from cells treated with dox for 5 days, because at
this time point most cells might undergo a few rounds of
division in an ABR-independent way. Consistent with a
previous report showing that the hESC line used here is sta-
ble in the karyotype during long-term culture (Interna-
tional Stem Cell Initiative et al., 2011), most of the control
cells retained the normal number of chromosomes (Fig-
ure 4D). On the other hand, when cultured with reduced
ABR expression, hESCs showed abnormal karyotypes
with a higher frequency (Figures 4D and S3C). Some of
them were tetraploid, which can result from mitosis skip
or cytokinesis failure, and notably, others showed a gain
or loss of some chromosomes (Figures 4E and S3C). Thus,
ABR dysfunction actually elevated the risk of aneuploidy,
highlighting a pivotal role of ABR in preventing aneu-
ploidy in cultured hESCs.
DISCUSSION
In this study, we explored ABR function in clump-cultured
hESCs.We first noticed that ABR depletion impeded G2-to-
M-to-G1 transitions. Deeper investigations at a single-cell
level revealed that ABR-depleted cells struggled to complete
a couple of mitotic steps, including centrosome separation
at prophase and chromosome alignment at metaphase.
These observations indicated that ABR has a crucial role
in mitosis progression. Important information lacking
now is subcellular localization of ABR. Our attempts to
determine its localization in hESCs did not work well, but
a large-scale proteomics analysis demonstrated ABR as a pu-
tative interactor of some centrosomal proteins (e.g., CEP25,
Fogeron et al., 2013), supporting our conclusion.
ABR seems to play a safeguarding role in mitotic fidelity,
in addition to being an apoptosis promoter in dissociated
cells (Figure S3D), and these different outcomes upon
ABR activation are dictated by the cellular adhesive
state, dissociation versus clumping. A previous report
demonstrated that the mitotic activation of actomyosin
sometimes stimulated cell death, mirroring the dissocia-
tion-induced phenotype (Barbaric et al., 2014). Consid-
ering that cellular adhesiveness is dynamically rearranged
duringmitosis, spontaneous failures in the adhesion-medi-
ated control of ABR activity could occur upon mitosis. An
intriguing possibility is that mitotic cells in which ABR
is inappropriately regulated might be intrinsically pro-
grammed to be eliminated, representing a mechanism
cell death (B), and extended mitosis (C) are shown. Yellow arrowheads indicate misaligned chromosomes. (D) The incidence of mitotic
errors. Cellular behaviors were categorized into the indicated three groups. Control (n = 146) and dox-treated cells (n = 87) were analyzed.
(E) The mitosis duration. In the cells that progressed into the next stage (classified as ‘‘division completion’’ in D), the time length from
NEB to abscission was categorized into the indicated five groups. Control (n = 144) and dox-treated cells (n = 72) were analyzed.
(F) Immunostaining analyses on metaphase-arrested tet-shABR cells that were treated or untreated with dox for 3 days. Nuclei (gray or
red) and TUBA (green) are shown. According to spindle morphology or chromosome positions, cellular phenotypes were classified into the
indicated five categories.
(G and H) The incidence of spindle malformation (G) and chromosome misalignment (H). Control (n = 94) and dox-treated cells (n = 52)
were analyzed.
The imaging experiments were repeated three times, and representative examples were shown (A, B, and C). The immunostaining was
performed two times with three replicates in each experiment (F). Scale bars represent 10 mm. See also Figure S2 and Movie S2.
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restraining expansion of genetically abnormal cells.
Consistently, it seems that ABR is not absolutely required
for mitosis completion, but mitosis without ABR is an er-
ror-prone process leading to frequent chromosome misse-
gregation. These results indicate that ABR sets a robust
way for chromosome segregation in hESCs. This might be
favorable, particularly to the self-renewing pluripotent
stem cells in which the postmitotic checkpoint signaling
is likely uncoupled to apoptosis-mediated elimination of
genetically abnormal cells (Mantel et al., 2007).
How ABR participates in the control of mitotic fidelity re-
mains an open question. Taking into consideration that
ABR action is correlated with a cellular adhesive state, the
present study suggests an unrecognized link between cell-
cell contact and mitotic fidelity. In general, most types of
non-transformed epithelial cells stop proliferation after
forming a polarized layer in confluent culture, a phenom-
enon known as ‘‘contact inhibition of proliferation’’
(McClatchey and Yap, 2012). In this regard, hESCs are an
atypical cell type: they can continue active growth within
densely packed polarized colonies. We previously reported
that the disconnection between cell-contact and nuclear
function of transcriptional cofactors YAP/TAZ allows this
type of unique proliferation (Ohgushi et al., 2015). From
another viewpoint, however, this unique mode of prolifer-
ation yields complex mechanical fields for mitotic cells,
Figure 4. Chromosome Missegregation
and Aneuploidy in ABR-Depleted Cells
(A) Snapshots from Movie S3. Yellow,
magenta, and green arrowheads indicate
misaligned chromosomes at metaphase,
lagging chromosomes at anaphase, and
micronuclei in daughter cells, respectively.
(B and C) Immunostaining analyses for
lagging chromosomes. Two representatives
from dox-treated samples are shown in (B)
(nuclei, red; centromeres, green). Magenta
arrowheads indicate centromere-positive
lagging chromosomes. Mitotic cells with
lagging chromosomes were counted and the
incidence was shown in (C). Control (n =
315) and dox-treated cells (n = 318) were
analyzed.
(D) Chromosome counting analyses. Mitotic
spreads were prepared using tet-shABR cells
that were treated or untreated with dox for
5 days. In each sample, 50 mitotic cells
were subjected to counting.
(E) Multicolor fluorescence in situ hybridi-
zation (FISH) analyses. The dox-treated
sample was stained with FISH probes for
each chromosome. Two independent ex-
periments were performed, and representa-
tive examples for normal and abnormal
karyotypes are shown.
The immunostaining was repeated three
times with five replicates in each experi-
ment (B and C). The mitotic spreads for
chromosome counting were prepared in
three separate experiments (D). Scale bars,
10 mm. Error bars in the graphs represent
SD. Statistics: Student’s t test (C, n = 3);
**p < 0.05. See also Figure S3 and Movie S3.
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because individual cells are constantly exposed to the
pushing or pulling forces from contacting adjacent cells.
On the basis of the observed high incidence of chromo-
some missegregation in ABR-depleted cells, our hypothesis
is that ABR buffers the noisy mechanical cues within a
multicellular society to confer robustness in the fidelity of
chromosome segregation during long-term expansion of
hESCs.
Unlike somatic cells in vivo, the proliferation of which is
limited to several division cycles, ESCs and iPSCs undergo
numerous rounds of genome replication and cell division
to fulfill the quantitative demand for their practical appli-
cations. This raises concerns about the accumulation of ge-
netic aberrations. Among them, aneuploidy is a particular
threat since some types of aneuploidy confer survival or
growth advantages that outcompete normal populations
(Spits et al., 2008; Avery et al., 2013; Nguyen et al., 2014).
Our findings provide implications for developing hESC cul-
ture methods that are better suited for human genetic
studies and cell-based therapies.
EXPERIMENTAL PROCEDURES
Cell Culture
All experiments usinghESC lineswere approved by an institutional
ethics committee and done following the hESC guidelines of the
Japanese government. Undifferentiated hESCs (KhES-1, Suemori
et al., 2006) were cultured on feeder layers of mouse embryonic
fibroblasts in D-MEM/F12 (Sigma) supplemented with 20%
KnockOut serum replacement, 2 mM glutamine, 0.1 mM non-
essential amino acids (Invitrogen), 5 ng/mL recombinant human
basic fibroblast growth factor (Wako), and 0.1 mM2-mercaptoetha-
nol. The culturemediumwas refresheddaily until thenext passage.
Immunostaining
Immunostaining was performed as described previously (Wata-
nabe et al., 2007). For analyses of metaphase-arrested cells, cells
were treated with 1 mg/mL MG132 for 1 hr and then immediately
subjected to immunostaining.
Live Imaging
For live imaging, hESC clumps were seeded onto an MEF-coated
35-mm m-dish (Ibidi). For confocal observations, serial images
were collected using a CSU-W1 unit (Yokogawa) configured with
an IX81-ZDC microscope (Olympus). The maximum projection
image was constructed from the obtained slices using MetaMorph
software.
Statistical Analyses
All experiments were performed at least three times, and error bars
in the graphs represent SDs. Statistical significance was tested by
Student’s t test for two-group comparison, and by one-way
ANOVA for multi-group comparison with Dunnett’s test using
Prime4 software (GraphPad).
SUPPLEMENTAL INFORMATION
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